Victor Purcarea

Learn More
Intravenous immunoglobulin (IVIg) is used to treat a number of immune deficiencies and autoimmune diseases. The pharmacokinetic proprieties of IVIg in healthy persons are well defined. The broad range of clinical applications of IVIg shows the importance of immunoglobulins in the immune homeostasis in healthy people. Intravenous immunoglobulin (IVIg) is an(More)
1-phenyl-3-methyl-4-benzoyl-5-pyrazolone 4-ethyl-thiosemicarbazone (HL) and its copper(II), vanadium(V) and nickel(II) complexes: [Cu(L)(Cl)]·C₂H₅OH·(1), [Cu(L)₂]·H₂O (2), [Cu(L)(Br)]·H₂O·CH₃OH (3), [Cu(L)(NO₃)]·2C₂H₅OH (4), [VO₂(L)]·2H₂O (5), [Ni(L)₂]·H₂O (6), were synthesized and characterized. The ligand has been characterized by elemental analyses, IR,(More)
It is well known by specialists and others that traumatic brain injury (TBI) is the main cause of death in young people under 40 years old and, at the same time, represents the cause of approximately two-thirds of post-traumatic deaths. Data from the World Health Organization show that 11,5 million Europeans who have survived traumatic brain injuries(More)
INTRODUCTION The Romanian health care system is facing a period of deep transformations, having in the last years some clear achievements, but also some acknowledged problems. Once the world's economic crisis appeared and manifested its first effects in Romanian economy, there will be some consequences in the health sector too. Regarding the Romanian social(More)
  • 1